Literature DB >> 1284953

Changes in type I keratin expression associated with HPV16 transformation of human epidermal keratinocytes.

X F Pei1, I M Leigh, F M Watt.   

Abstract

We have used immunoblotting to compare expression of type I keratins in two strains of normal human epidermal keratinocytes (v and u) and their HPV16-transformed derivatives (vp and up). The levels of keratins 14 and 17 were similar in all four cell strains, whereas keratins 18 and 19 were more abundant in vp and up than in the normal parental keratinocytes. Keratin 13 was more abundant in the transformed cells than in the parentals; in addition, expression in v was higher than in u, and expression in vp was higher than in up, suggesting strain-specific variation in expression. Keratin 16 was the only keratin to be more highly expressed in v and u than in vp and up; this is consistent with the reduced capacity of the transformants for stratification and terminal differentiation. Double-label immunofluorescence of vp and up showed that more cells expressed involucrin than keratin 16. We conclude that HPV16 transformation results in marked changes in keratin expression. The increased expression of keratin 18, a keratin that is normally expressed in simple epithelia, fits well with reports of increased keratin 18 expression in invasive squamous cell carcinomas of skin and other keratinocyte-derived tumours.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284953

Source DB:  PubMed          Journal:  Epithelial Cell Biol        ISSN: 0940-9912


  2 in total

1.  Redox regulation of cytokeratin 18 protein by NADPH oxidase 1 in preneoplastic human epithelial cells.

Authors:  Apsorn Sattayakhom; Wanida Ittiwat; Wolfgang Stremmel; Walee Chamulitrat
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-30       Impact factor: 4.553

2.  Internalization of Staphylococcus aureus by human keratinocytes.

Authors:  Sompid Kintarak; Simon A Whawell; Paul M Speight; Samantha Packer; Sean P Nair
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.